Jacobs Levy Equity Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-41,667	Closed	-$753K	–	1060
2023 Q2	$753K	Buy	+41,667	New	+$753K	﹤0.01%	748
2022 Q4	–	Sell	-86,948	Closed	-$1.49M	–	1035
2022 Q3	$1.49M	Buy	86,948 +4,906	+6%	+$84K	0.01%	619
2022 Q2	$1.2M	Buy	+82,042	New	+$1.2M	0.01%	715